|  |  | Cementless/cement |  |  |  | ||||
---|---|---|---|---|---|---|---|---|---|---|
Studies | country | Study design | Cases | Age | BMI | Female | Revision rate(%) | Prosthesis | Power analysis | Follow-up |
Abu-rajab 2006 [23] | UK | Non-RCT | 20/18 | 69/71 | – | 11/8 | – | – | Y | 2 years |
Anis 2019 [24] | USA | Non-RCT | 133/132 | 60/62 | 33/33 | 51/44 | 2.3/1.5 | – | N | 2 years |
Bagsby 2016 [25] | USA | Non-RCT | 145/154 | 62.7/58.8 | 44.7/45.6 | 102/122 | 0.7/13 | Stryker Triathlon | N | 3.65 years |
Baker 2007 [13] | UK | RCT | 224/277 | 71/70 | Â | 103/121 | 8.9/8.7 | PFC | N | 8.7 years |
Boyle et al. 2017 [26] | USA | Non-RCT | 154/171 | 59.6/64.9 | 37.4/37.4 | 97/128 | 3.9/3.5 | Stryker Triathlon | N | 5.7 years |
Carlsson 2005 [14] | Sweden | RCT | 27/29 | 74/72 | – | 20/22 | 3.7/0 | PFC | N | 5 years |
Dodd 1990 [27] | UK | Non-RCT | 18/18 | – | – | 15/15 | 5.6/5.6 | PCA | N | 5 years |
Duffy 1998 [28] | USA | Non-RCT | 55/51 | 54/65 | 29.07/27.63 | 23/24 | 16.4/5.9 | PFC | N | 10.2 years |
Fernandez-Fairen 2013 [15] | Switzerland | RCT | 74/71 | 61/60 | 29.1/30.5 | 55/54 | 0/1.6 | NexGen CR | Y | 5 years |
Fricka 2015 [16] | USA | RCT | 47/46 | 60.2/58.6 | 31.4/32.7 | 29/33 | 2.1/2.2 | NexGen CR | Y | 2 years |
Fricka 2019 [17] | USA | RCT | 41/44 | 59.8/58.4 | 31.4/31.9 | 26/31 | 4.9/2.3 | NexGen CR | Y | 5 years |
Gao 2009 [18] | Sweden | RCT | 19/22 | – | – | – | 5.3/0 | NexGen CR | Y | 2 years |
Kamath 2011 [29] | USA | Non-RCT | 100/312 | 55/63 | – | – | 2/1.6 | NexGen CR | N | 5 years |
Karachalios 2018 [30] | Greek | Non-RCT | 54/54 | 63.2/63.8 | 32/31.5 | 36/37 | – | aMP system | Y | 8.6 years |
Khaw 2002 [19] | UK | RCT | 177/219 | 71/70 | – | 103/121 | 3.95/4.11 | PFC | N | 7.3 years |
Kim 2014 [2] | Korea | RCT | 80/80 | 54.3/54.3 | 27.8/27.8 | 63/63 | 1.25/0 | NexGen CR | Y | 16.6 years |
McCaskie 1998 [20] | UK | RCT | 58/81 | 70.2/68.8 | – | 32/49 | – | PFC | N | 5 years |
Miller et al. 2017 [31] | USA | Non-RCT | 200/200 | 64.3/64.4 | 33.9/33.1 | 125/125 | 3.5/4 | Stryker Triathlon | N | 5.3 years |
Nam 2019 [21] | USA | RCT | 76/65 | 61.3/63 | 31.1/31.3 | 36/34 | 0/1.5 | Stryker Triathlon | Y | 2 years |
Pap 2018 [32] | Hungary | Non-RCT | 134/140 | 59/69 | Â | 53/64 | 1.5/1.4 | SanatSwing | N | 2 years |
Park 2011 [22] | Korea | RCT | 50/50 | 58.4/58.4 | 26.6/26.6 | 39/39 | 2/0 | NexGen CR | Y | 13.6 years |
Pecina 2000 [33] | Croatia | Non-RCT | 87/44 | 57/62 | – | – | 22.99/15.91 | PCA | N | 7.3 years |
Prudhon 2017 [34] | France | Non-RCT | 100/100 | 72.3/73.2 | – | 57/59 | 5/10 | NEW WAVETM | N | 12.1 years |
Rand 1991 [35] | USA | Non-RCT | 59/59 | 57/66 | 29.4/24.4 | 24/25 | – | PFC | N | 2.8 years |
Rosenberg 1990 [36] | USA | Non-RCT | 132/139 | 59/70 |  | 77/82 | 4.5/5.8 | – | N | 3.6 years |
Sinicrope et al. 2018 [37] | USA | Non-RCT | 108/85 | 62/60 | 45.6/45 | 82/67 | 4.63/25.88 | Stryker Triathlon | Y | 5 years |